About Asmacure
Asmacure is a company based in Quebec City (Canada) founded in 2002 was acquired by Odan Laboratories in August 2015.. Asmacure has raised $16.93 million across 3 funding rounds from investors including Innovatech Québec, Domain Associates and Odan Laboratories Ltd.. Asmacure operates in a competitive market with competitors including aTyr Pharma, ReCode Therapeutics, InterMune, GEn1E and Pulmatrix, among others.
- Headquarter Quebec City, Canada
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$16.93 M (USD)
in 3 rounds
-
Latest Funding Round
$4 M (USD), Series A
May 17, 2011
-
Investors
Innovatech Québec
& 2 more
-
Employee Count
Employee Count
-
Acquired by
Odan Laboratories
(Aug 19, 2015)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Asmacure
Asmacure has successfully raised a total of $16.93M across 3 strategic funding rounds. The most recent funding activity was a Series A round of $4 million completed in May 2011. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Series A — $4.0M
-
First Round
First Round
(08 May 2007)
- Investors Count 2
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2011 | Amount | Series A - Asmacure | Valuation |
investors |
|
| Feb, 2010 | Amount | Series A - Asmacure | Valuation |
investors |
|
| May, 2007 | Amount | Series A - Asmacure | Valuation | Innovatech Quebec , Domain Associates |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Asmacure
Asmacure has secured backing from 3 investors, including venture fund investors. Prominent investors backing the company include Innovatech Québec, Domain Associates and Odan Laboratories Ltd.. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early stage venture capital investments are made in technology sectors.
|
Founded Year | Domain | Location | |
|
Life science & tech focused VC firm investing in the US
|
Founded Year | Domain | Location | |
|
Odan Laboratories Ltd. is recognized as a leader in generic pharmaceuticals in Canada.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Asmacure
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Asmacure
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Asmacure Comparisons
Competitors of Asmacure
Asmacure operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as aTyr Pharma, ReCode Therapeutics, InterMune, GEn1E and Pulmatrix, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Protein biologics are developed for treating rare diseases.
|
|
| domain | founded_year | HQ Location |
Precision medicines for lung-related diseases are developed.
|
|
| domain | founded_year | HQ Location |
Therapies in pulmonology and orphan fibrotic diseases.
|
|
| domain | founded_year | HQ Location |
Developer of therapeutics for the treatment of inflammatory and rare diseases
|
|
| domain | founded_year | HQ Location |
Developer of therapeutics for the treatment of respiratory diseases
|
|
| domain | founded_year | HQ Location |
Small molecule therapeutics are developed for various diseases.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Asmacure
Frequently Asked Questions about Asmacure
When was Asmacure founded?
Asmacure was founded in 2002 and raised its 1st funding round 5 years after it was founded.
Where is Asmacure located?
Asmacure is headquartered in Quebec City, Canada. It is registered at Quebec City, Quebec, Canada.
Is Asmacure a funded company?
Asmacure is a funded company, having raised a total of $16.93M across 3 funding rounds to date. The company's 1st funding round was a Series A of $9M, raised on May 08, 2007.
What does Asmacure do?
Asmacure is a clinical-stage biopharmaceutical company that develops compounds that target cholinergic receptors for the treatment of pulmonary diseases. The companys lead compound, ASM-024, is a dry powder for inhalation formulation developed for Asthma. The company claims, ASM-024, has demonstrated inhibitory effects on inflammation, bronchoprotective and smooth muscle relaxation in pre-clinical asthma models. The company also claims that ASM-024 has been safely administered to 200 humans via the oral route and inhalation route, i.e. nebulization of a solution and dry powder formulation. In 2015, Odan Laboratories acquired Asmacure.
Who are the top competitors of Asmacure?
Asmacure's top competitors include aTyr Pharma, ReCode Therapeutics and Pulmatrix.
Who are Asmacure's investors?
Asmacure has 3 investors. Key investors include Innovatech Québec, Domain Associates, and Odan Laboratories Ltd..